Verstovsek, Srdan
Pemmaraju, Naveen
Reaven, Nancy L. http://orcid.org/0000-0002-1636-0735
Funk, Susan E.
Woody, Tracy
Valone, Frank
Gupta, Suneel
Funding for this research was provided by:
Protagonist Therapeutics
Article History
Received: 7 November 2022
Accepted: 29 December 2022
First Online: 13 January 2023
Declarations
:
: This retrospective database analysis used de-identified data. As such, Institutional Review Board (IRB) approval to conduct this analysis was not required nor was patient consent required. This analysis complies with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and its implementing regulations of Title 45 Code of Federal Regulations Parts 160 and 164 (“HIPAA Privacy and Security Rules”).
: All authors consent to publication.
: S. Verstovsek and N. Pemmaraju have received research support for conduct of clinical studies for Protagonist Therapeutics, Inc. N. Reaven, S. Funk, and F. Valone received consulting fees for work provided in support of this manuscript. T. Woody and S. Gupta are/were employees of Protagonist Therapeutics at the time of the research and/or writing phase of this manuscript.